Islatravir plus lenacapavir could be the first once-weekly oral HIV ...
Mar 6, 2024 · A once-weekly oral regimen can keep HIV suppressed as well as daily pills, according to study results presented today at the Conference on Retroviruses and Opportunistic Infections (CROI 2024).. In a phase II clinical trial, 94% of people who switched to weekly islatravir and lenacapavir pills maintained an undetectable viral load, matching the viral suppression rate of those who stayed on ...
aidsmap | aidsmap
After 37 years of pioneering health journalism, community engagement, and empowerment through information, we have now ceased operations. This website will be accessible until September 2025, with all the information being up to date as of July 2024.
Estimated HIV risk per exposure - Aidsmap
After 37 years of pioneering health journalism, community engagement, and empowerment through information, we have now ceased operations. This website will be accessible until September 2025, with all the information being up to date as of July 2024.
The stages of HIV infection - Aidsmap
Most descriptions of the stages of HIV infection describe the natural history of HIV, in other words how, over time, the disease progresses in people who are not taking HIV treatment. They show how HIV progressively attacks and weakens the immune system, eventually leading to AIDS (acquired immune deficiency syndrome).
Is the CD4/CD8 ratio a useful test for people with HIV?
Feb 23, 2024 · Monitoring of CD4/CD8 ratios should not be abandoned as HIV treatment programmes switch to streamlined monitoring, researchers from the University of Wisconsin argue in the journal AIDS.. Highlighting recently published research that shows the value of CD4/CD8 ratios for predicting who is at greater risk of cancer and weak vaccine responses, they say that the CD4/CD8 ratio remains an important ...
Top 5 HIV treatment stories from CROI 2024 - Aidsmap
Mar 18, 2024 · After 37 years of pioneering health journalism, community engagement, and empowerment through information, we have now ceased operations. This website will be accessible until September 2025, with all the information being up to date as of July 2024.
Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) Emtricitabine 200mg capsule 1 Common: Nausea, diarrhoea, vomiting, indigestion, headache, dizziness, weakness, fatigue, raised liver enzyme, amylase or creatine kinase levels, raised blood sugar and triglyceride levels, rash, itching, skin darkening, insomnia, abnormal dreams
Antiretroviral drug chart Generic name Trade name Formulation Standard adult dose Pills/ day Major side effects Food requirements Tenofovir disoproxil
Biktarvy - Aidsmap
What is Biktarvy?. Biktarvy is a medication used to treat HIV. It is a combination of three separate antiretroviral drugs in one pill, taken once a day. It combines 50mg of bictegravir, 200mg of emtricitabine and 25mg of tenofovir alafenamide in a purplish-brown tablet with ‘GSI’ on one side and ‘9883’ on the other side of the tablet.. How does Biktarvy work?
Gammora does not cure HIV - Aidsmap
Nov 6, 2018 · After 37 years of pioneering health journalism, community engagement, and empowerment through information, we have now ceased operations. This website will be accessible until September 2025, with all the information being up to date as of July 2024.